Da fluoxetin har samme metaboliske profil som paroxetin, dvs. stærk CYP2D6- hæmmende virkning, forventes samme mangel på interaktion for fluoxetin.
Since fluoxetine shares a similar metabolic profile with paroxetine, i. e. a strong CYP2D6 inhibitory effect, a similar lack of interaction would be expected for fluoxetine.